CD8A and neoplasm: These mechanisms, which range from immunosuppressive regulatory T cells (Treg) and Myeloid-Derived Suppressor cells to metabolic changes that inhibit cytotoxic T cell activity [2, 3], will have to be overcome in order for the transferred CD8+ T cells to efficiently attack the tumor.